ResearcherTongji UniversityNo recent work listed
Tao Chen
Matched on ORCID iD 0000-0002-1797-0359; OpenAlex author ID A5100357735. Sources: ClinicalTrials.gov.
Their work
- Papers
- 7 (first author 1, last author 1)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2014: 1 paper · 2015: 3 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 trial · 2022: none · 2023: 2 papers
Papers 7
- Causality-Driven Graph Neural Network for Early Diagnosis of Pancreatic Cancer in Non-Contrast Computerized Tomography. Co-author DOI 10.1109/tmi.2023.3236162↗
- Development and validation of an MRI-radiomics nomogram for the prognosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2023.1074445↗
- Risk factors and socio-economic burden in pancreatic ductal adenocarcinoma operation: a machine learning based analysis. Last author DOI 10.1186/s12885-020-07626-2↗
- Preoperative serum CA125 levels predict the prognosis in hyperbilirubinemia patients with resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/md.0000000000000751↗
- Retraction Notice to: Normalization of CA19-9 Following Resection for Pancreatic Ductal Adenocarcinoma is not Tantamount to being Cured? Co-author DOI 10.7314/apjcp.2015.16.13.5587↗
- Normalization of CA19-9 following resection for pancreatic ductal adenocarcinoma is not tantamount to being cured? Co-author DOI 10.7314/apjcp.2015.16.2.661↗
- Metabolic tumour burden assessed by ¹⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection. First author DOI 10.1007/s00259-014-2688-8↗
Trials 1
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaohua Qian · 2 shared papers, 2023 · strength 0.46
- Paper Causality-Driven Graph Neural Network for Early Diagnosis of Pancreatic Cancer in Non-Contrast Computerized Tomography. DOI 10.1109/tmi.2023.3236162↗
- Paper Development and validation of an MRI-radiomics nomogram for the prognosis of pancreatic ductal adenocarcinoma. DOI 10.3389/fonc.2023.1074445↗
- Yijue Zhang · 2 shared papers, 2020–2023 · strength 0.32
- Paper Development and validation of an MRI-radiomics nomogram for the prognosis of pancreatic ductal adenocarcinoma. DOI 10.3389/fonc.2023.1074445↗
- Paper Risk factors and socio-economic burden in pancreatic ductal adenocarcinoma operation: a machine learning based analysis. DOI 10.1186/s12885-020-07626-2↗
- Xianjun Yu · 4 shared papers, 2014–2015 · strength 0.24
- Paper Retraction Notice to: Normalization of CA19-9 Following Resection for Pancreatic Ductal Adenocarcinoma is not Tantamoun… DOI 10.7314/apjcp.2015.16.13.5587↗
- Paper Normalization of CA19-9 following resection for pancreatic ductal adenocarcinoma is not tantamount to being cured? DOI 10.7314/apjcp.2015.16.2.661↗
- Paper Preoperative serum CA125 levels predict the prognosis in hyperbilirubinemia patients with resectable pancreatic ductal … DOI 10.1097/md.0000000000000751↗
- Xinyue Li · 1 shared paper, 2023 · strength 0.24
- Yingbin Liu · 1 shared paper, 2023 · strength 0.22
- Xinsen Xu · 1 shared paper, 2023 · strength 0.22
- Liang Liu · 3 shared papers, 2014–2015 · strength 0.17
- Paper Normalization of CA19-9 following resection for pancreatic ductal adenocarcinoma is not tantamount to being cured? DOI 10.7314/apjcp.2015.16.2.661↗
- Paper Preoperative serum CA125 levels predict the prognosis in hyperbilirubinemia patients with resectable pancreatic ductal … DOI 10.1097/md.0000000000000751↗
- Paper Metabolic tumour burden assessed by ¹⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome afte… DOI 10.1007/s00259-014-2688-8↗
- Wen-Quan Wang · 2 shared papers, 2014–2015 · strength 0.10
- Paper Preoperative serum CA125 levels predict the prognosis in hyperbilirubinemia patients with resectable pancreatic ductal … DOI 10.1097/md.0000000000000751↗
- Paper Metabolic tumour burden assessed by ¹⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome afte… DOI 10.1007/s00259-014-2688-8↗
- Huaxiang Xu · 2 shared papers, 2014–2015 · strength 0.10
- Paper Preoperative serum CA125 levels predict the prognosis in hyperbilirubinemia patients with resectable pancreatic ductal … DOI 10.1097/md.0000000000000751↗
- Paper Metabolic tumour burden assessed by ¹⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome afte… DOI 10.1007/s00259-014-2688-8↗
- Liang Liu · 1 shared paper, 2015 · strength 0.07
- Jin Xu · 1 shared paper, 2014 · strength 0.04
- Jiang Long · 1 shared paper, 2014 · strength 0.04
- Chuntao Wu · 1 shared paper, 2014 · strength 0.04
- Chen Liu · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.